Rituximab use in pediatric central demyelinating disease

SJ Beres, J Graves, E Waubant - Pediatric neurology, 2014 - Elsevier
Background Rituximab is a B-cell therapy used off-label to reduce relapses in adult
demyelinating diseases. There is limited knowledge of its clinical use in pediatric …
被引用次数：77 相关文章

Rituximab use in pediatric central demyelinating disease

SJ Beres, J Graves, E Waubant - Pediatric neurology, 2014 - pubmed.ncbi.nlm.nih.gov
Background Rituximab is a B-cell therapy used off-label to reduce relapses in adult
demyelinating diseases. There is limited knowledge of its clinical use in pediatric …

Rituximab Use in Pediatric Central Demyelinating Disease

SJ Beres, J Graves, E Waubant - Pediatric Neurology, 2014 - infona.pl
Rituximab is a B-cell therapy used off-label to reduce relapses in adult demyelinating
diseases. There is limited knowledge of its clinical use in pediatric neuromyelitis optica and …

Rituximab Use in Pediatric Central Demyelinating Disease

SJ Beres, J Graves, E Waubant - Pediatric Neurology, 2014 - pedneur.com
Background Rituximab is a B-cell therapy used off-label to reduce relapses in adult
demyelinating diseases. There is limited knowledge of its clinical use in pediatric …

Rituximab use in pediatric central demyelinating disease.

SJ Beres, J Graves, E Waubant - Pediatric Neurology, 2014 - europepmc.org
Background Rituximab is a B-cell therapy used off-label to reduce relapses in adult
demyelinating diseases. There is limited knowledge of its clinical use in pediatric …